The ‘intermediate’ CD14++CD16+ Mo also displayed BPs involved in ‘positive regulation of SMC proliferation’ and ‘positive regulation of/response to vascular VEGF/epidermal growth factor receptor (EGFR)/fibroblast growth factor (FGF)’, indicating that these two subpopulations may also promote liver fibrosis. The gene discussed is EGFR; the disease is Hepatic fibrosis.